A Safety and Biomarker Study of ALZT-OP1a in Subjects With Mild-Moderate ALS Disease

NCT04428775 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

12

Enrollment

INDUSTRY

Sponsor class

Stopped Low enrollment

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: ALZT-OP1a (cromolyn)

Sponsor

AZTherapies, Inc.